BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol 2014; 20(33): 11505-11524 [PMID: 25206258 DOI: 10.3748/wjg.v20.i33.11505] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 88] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Kanmani P, Kim H. Functional capabilities of probiotic strains on attenuation of intestinal epithelial cell inflammatory response induced by TLR4 stimuli. BioFactors 2018;45:223-35. [DOI: 10.1002/biof.1475] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
2 Vemuri R, Shinde T, Shastri MD, Perera AP, Tristram S, Martoni CJ, Gundamaraju R, Ahuja KDK, Ball M, Eri R. A human origin strain Lactobacillus acidophilus DDS-1 exhibits superior in vitro probiotic efficacy in comparison to plant or dairy origin probiotics. Int J Med Sci 2018;15:840-8. [PMID: 30008595 DOI: 10.7150/ijms.25004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
3 Derikx LA, Dieleman LA, Hoentjen F. Probiotics and prebiotics in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2016;30:55-71. [DOI: 10.1016/j.bpg.2016.02.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
4 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. [PMID: 26582965 DOI: 10.1155/2015/628157] [Cited by in Crossref: 221] [Cited by in F6Publishing: 212] [Article Influence: 31.6] [Reference Citation Analysis]
6 Oliver L, Ramió-Pujol S, Amoedo J, Malagón M, Serrano M, Bahí A, Lluansí A, Torrealba L, Busquets D, Pardo L, Serra-Pagès M, Aldeguer X, Garcia-Gil J. A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples. Front Microbiol 2021;12:639948. [PMID: 33833742 DOI: 10.3389/fmicb.2021.639948] [Reference Citation Analysis]
7 Song J, Li Q, Li P, Liu R, Cui H, Zheng M, Everaert N, Zhao G, Wen J. The effects of inulin on the mucosal morphology and immune status of specific pathogen-free chickens. Poult Sci 2018;97:3938-46. [PMID: 29992311 DOI: 10.3382/ps/pey260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Murad HA, Abdallah HM, Ali SS. Mentha longifolia protects against acetic-acid induced colitis in rats. J Ethnopharmacol 2016;190:354-61. [PMID: 27282663 DOI: 10.1016/j.jep.2016.06.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
9 Lobatón T, Domènech E. Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile. Inflamm Bowel Dis 2016;22:1755-62. [PMID: 27104824 DOI: 10.1097/MIB.0000000000000788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
10 Simčič S, Berlec A, Stopinšek S, Štrukelj B, Orel R. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa. World J Microbiol Biotechnol 2019;35:45. [PMID: 30810891 DOI: 10.1007/s11274-019-2615-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. [PMID: 26528128 DOI: 10.3389/fncel.2015.00392] [Cited by in Crossref: 366] [Cited by in F6Publishing: 364] [Article Influence: 52.3] [Reference Citation Analysis]
12 Gholam-Mostafaei FS, Yadegar A, Asadzadeh Aghdaei H, Shahrokh S, Ebrahimi Daryani N, Zali MR. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis. Acta Microbiol Immunol Hung 2021. [PMID: 34383708 DOI: 10.1556/030.2021.01498] [Reference Citation Analysis]
13 Fan L, Zuo S, Tan H, Hu J, Cheng J, Wu Q, Nie S. Preventive effects of pectin with various degrees of esterification on ulcerative colitis in mice. Food Funct 2020;11:2886-97. [DOI: 10.1039/c9fo03068a] [Cited by in Crossref: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Babickova J, Gardlik R. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11321-11330 [PMID: 26525290 DOI: 10.3748/wjg.v21.i40.11321] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
15 Guandalini S, Sansotta N. Probiotics in the Treatment of Inflammatory Bowel Disease. Adv Exp Med Biol 2019;1125:101-7. [PMID: 30632114 DOI: 10.1007/5584_2018_319] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
16 Pereira MS, Munerato MC. Oral Manifestations of Inflammatory Bowel Diseases: Two Case Reports. Clin Med Res 2016;14:46-52. [PMID: 26864508 DOI: 10.3121/cmr.2015.1307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Skenderidis P, Mitsagga C, Lampakis D, Petrotos K, Giavasis I. The Effect of Encapsulated Powder of Goji Berry (Lycium barbarum) on Growth and Survival of Probiotic Bacteria. Microorganisms 2019;8:E57. [PMID: 31905688 DOI: 10.3390/microorganisms8010057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
18 Chibbar R, Alahmadi A, Dieleman L. Treatment of Inflammatory Bowel Disease in Ulcerative Colitis. The Microbiota in Gastrointestinal Pathophysiology. Elsevier; 2017. pp. 343-54. [DOI: 10.1016/b978-0-12-804024-9.00037-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol 2016; 22(32): 7186-7202 [PMID: 27621567 DOI: 10.3748/wjg.v22.i32.7186] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
20 Orel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol 2014; 20(33): 11505-11524 [PMID: 25206258 DOI: 10.3748/wjg.v20.i33.11505] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 88] [Article Influence: 13.3] [Reference Citation Analysis]
21 Paściak M, Górska S, Jawiarczyk N, Gamian A. Lactobacillus johnsonii glycolipids, their structure and immunoreactivity with sera from inflammatory bowel disease patients. Microb Biotechnol 2017;10:456-68. [PMID: 27766756 DOI: 10.1111/1751-7915.12424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Chibbar R, Dieleman LA. Probiotics in the Management of Ulcerative Colitis. Journal of Clinical Gastroenterology 2015;49:S50-5. [DOI: 10.1097/mcg.0000000000000368] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
23 Saracino MP, Vila CC, Baldi PC, González Maglio DH. Searching for the one(s): Using Probiotics as Anthelmintic Treatments. Front Pharmacol 2021;12:714198. [PMID: 34434110 DOI: 10.3389/fphar.2021.714198] [Reference Citation Analysis]
24 Chaen Y, Yamamoto Y, Suzuki T. Naringenin promotes recovery from colonic damage through suppression of epithelial tumor necrosis factor–α production and induction of M2-type macrophages in colitic mice. Nutrition Research 2019;64:82-92. [DOI: 10.1016/j.nutres.2019.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Ghattamaneni NKR, Panchal SK, Brown L. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease. Pharmacol Res 2018;132:99-107. [PMID: 29680446 DOI: 10.1016/j.phrs.2018.04.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
26 Cinque B, La Torre C, Lombardi F, Palumbo P, Van der Rest M, Cifone MG. Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation. PLoS One 2016;11:e0163216. [PMID: 27657913 DOI: 10.1371/journal.pone.0163216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
27 Alagón Fernández Del Campo P, De Orta Pando A, Straface JI, López Vega JR, Toledo Plata D, Niezen Lugo SF, Alvarez Hernández D, Barrientos Fortes T, Gutiérrez-Kobeh L, Solano-Gálvez SG, Vázquez-López R. The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Med Sci (Basel) 2019;7:E33. [PMID: 30813381 DOI: 10.3390/medsci7020033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Panasevich MR, Allen JM, Wallig MA, Woods JA, Dilger RN. Moderately Fermentable Potato Fiber Attenuates Signs and Inflammation Associated with Experimental Colitis in Mice. The Journal of Nutrition 2015;145:2781-8. [DOI: 10.3945/jn.115.218578] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
30 Aggeletopoulou I, Konstantakis C, Assimakopoulos SF, Triantos C. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microb Pathog 2019;137:103774. [PMID: 31586663 DOI: 10.1016/j.micpath.2019.103774] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
31 Manuc TE, Manuc MM, Diculescu MM. Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets. Clin Exp Gastroenterol 2016;9:59-70. [PMID: 27042137 DOI: 10.2147/CEG.S53381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
32 Chen Y, Zhang L, Hong G, Huang C, Qian W, Bai T, Song J, Song Y, Hou X. Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced chronic colitis. Life Sci 2020;240:117089. [PMID: 31759038 DOI: 10.1016/j.lfs.2019.117089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
33 Fernández J, Redondo-blanco S, Gutiérrez-del-río I, Miguélez EM, Villar CJ, Lombó F. Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: A review. Journal of Functional Foods 2016;25:511-22. [DOI: 10.1016/j.jff.2016.06.032] [Cited by in Crossref: 131] [Cited by in F6Publishing: 77] [Article Influence: 21.8] [Reference Citation Analysis]
34 Chen X, Zhao X, Wang H, Yang Z, Li J, Suo H. Prevent Effects of Lactobacillus Fermentum HY01 on Dextran Sulfate Sodium-Induced Colitis in Mice. Nutrients 2017;9:E545. [PMID: 28587089 DOI: 10.3390/nu9060545] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
35 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine. Elsevier; 2018. pp. 501-516.e8. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Barnes D, Yeh AM. Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children. Nutr Clin Pract. 2015;30:747-759. [PMID: 26538058 DOI: 10.1177/0884533615610081] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
37 Verma M, Hontecillas R, Abedi V, Leber A, Tubau-Juni N, Philipson C, Carbo A, Bassaganya-Riera J. Modeling-Enabled Systems Nutritional Immunology. Front Nutr 2016;3:5. [PMID: 26909350 DOI: 10.3389/fnut.2016.00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
38 Tamang JP, Shin DH, Jung SJ, Chae SW. Functional Properties of Microorganisms in Fermented Foods. Front Microbiol 2016;7:578. [PMID: 27199913 DOI: 10.3389/fmicb.2016.00578] [Cited by in Crossref: 149] [Cited by in F6Publishing: 110] [Article Influence: 24.8] [Reference Citation Analysis]
39 Qi Y, Lohman J, Bratlie KM, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Yoon KJ, Barrett TA, Wang Q. Vitamin C and B3 as new biomaterials to alter intestinal stem cells. J Biomed Mater Res A 2019;107:1886-97. [PMID: 31071241 DOI: 10.1002/jbm.a.36715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Hu W, Xu D, Zhou Z, Zhu J, Wang D, Tang J. Alterations in the gut microbiota and metabolic profiles coincide with intestinal damage in mice with a bloodborne Candida albicans infection. Microb Pathog 2021;154:104826. [PMID: 33689815 DOI: 10.1016/j.micpath.2021.104826] [Reference Citation Analysis]
41 Tang J, Liu J, Yan Q, Gu Z, August A, Huang W, Jiang Z. Konjac Glucomannan Oligosaccharides Prevent Intestinal Inflammation Through SIGNR1-Mediated Regulation of Alternatively Activated Macrophages. Mol Nutr Food Res 2021;:e2001010. [PMID: 34390195 DOI: 10.1002/mnfr.202001010] [Reference Citation Analysis]
42 Guo J, Liao M, Zhu Y, Hu X, Wang J. The protective role of Chitooligosaccharides against chronic ulcerative colitis induced by dextran sulfate sodium in mice. Journal of Functional Foods 2021;87:104809. [DOI: 10.1016/j.jff.2021.104809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Di Stasi LC, Costa CA, Witaicenis A. Products for the treatment of inflammatory bowel disease: a patent review (2013 - 2014). Expert Opin Ther Pat 2015;25:629-42. [PMID: 25944127 DOI: 10.1517/13543776.2015.1041921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
44 Yoon JW, Ahn SI, Jhoo JW, Kim GY. Antioxidant Activity of Yogurt Fermented at Low Temperature and Its Anti-inflammatory Effect on DSS-induced Colitis in Mice. Food Sci Anim Resour 2019;39:162-76. [PMID: 30882084 DOI: 10.5851/kosfa.2019.e13] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
45 Wang X, Xie L, Long J, Liu K, Lu J, Liang Y, Cao Y, Dai X, Li X. Therapeutic effect of baicalin on inflammatory bowel disease: A review. J Ethnopharmacol 2022;283:114749. [PMID: 34666140 DOI: 10.1016/j.jep.2021.114749] [Reference Citation Analysis]
46 Wang X, Xiao K, Yu C, Wang L, Liang T, Zhu H, Xu X, Liu Y. Xylooligosaccharide attenuates lipopolysaccharide-induced intestinal injury in piglets via suppressing inflammation and modulating cecal microbial communities. Anim Nutr 2021;7:609-20. [PMID: 34377847 DOI: 10.1016/j.aninu.2020.11.008] [Reference Citation Analysis]
47 Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int 2014;2014:567929. [PMID: 25580435 DOI: 10.1155/2014/567929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
48 Vray M, Hedible BG, Adam P, Tondeur L, Manirazika A, Randremanana R, Mainassara H, Briend A, Artaud C, von Platen C, Altmann M, Jambou R. A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project). Trials 2018;19:666. [PMID: 30514364 DOI: 10.1186/s13063-018-3027-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 McKay R, Ghodasra M, Schardt J, Quan D, Pottash AE, Shang W, Jay SM, Payne GF, Chang MW, March JC, Bentley WE. A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease. Bioeng Transl Med 2018;3:209-21. [PMID: 30377661 DOI: 10.1002/btm2.10113] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
50 Gaforio JJ, Visioli F, Alarcón-de-la-Lastra C, Castañer O, Delgado-Rodríguez M, Fitó M, Hernández AF, Huertas JR, Martínez-González MA, Menendez JA, Osada J, Papadaki A, Parrón T, Pereira JE, Rosillo MA, Sánchez-Quesada C, Schwingshackl L, Toledo E, Tsatsakis AM. Virgin Olive Oil and Health: Summary of the III International Conference on Virgin Olive Oil and Health Consensus Report, JAEN (Spain) 2018. Nutrients 2019;11:E2039. [PMID: 31480506 DOI: 10.3390/nu11092039] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 14.3] [Reference Citation Analysis]
51 Gong J, Bai T, Zhang L, Qian W, Song J, Hou X. Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro. PLoS One 2017;12:e0189257. [PMID: 29216305 DOI: 10.1371/journal.pone.0189257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
52 Cui J, Wang F, Zhao C, Zhou S, Zheng J. Orange Pectin with Compact Conformation Effectively Alleviates Acute Colitis in Mice. J Agric Food Chem 2022. [PMID: 35080177 DOI: 10.1021/acs.jafc.1c07951] [Reference Citation Analysis]
53 Souza ÉL, Elian SD, Paula LM, Garcia CC, Vieira AT, Teixeira MM, Arantes RM, Nicoli JR, Martins FS. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. Journal of Medical Microbiology 2016;65:201-10. [DOI: 10.1099/jmm.0.000222] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
54 Zha Z, Lv Y, Tang H, Li T, Miao Y, Cheng J, Wang G, Tan Y, Zhu Y, Xing X, Ding K, Wang Y, Yin H. An orally administered butyrate-releasing xylan derivative reduces inflammation in dextran sulphate sodium-induced murine colitis. Int J Biol Macromol 2020;156:1217-33. [PMID: 31759015 DOI: 10.1016/j.ijbiomac.2019.11.159] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
55 Xiong Y, Zhang F, Li J, Peng P, Liu B, Zhao L. Ganoderma lucidum protease hydrolyzate on lipid metabolism and gut microbiota in high-fat diet fed rats. Food Bioscience 2022;47:101460. [DOI: 10.1016/j.fbio.2021.101460] [Reference Citation Analysis]
56 Rufino MN, da Costa AL, Jorge EN, Paiano VF, Camparoto ML, Keller R, Bremer-Neto H. Synbiotics improve clinical indicators of ulcerative colitis: systematic review with meta-analysis. Nutr Rev 2021:nuab017. [PMID: 34010402 DOI: 10.1093/nutrit/nuab017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, Hibi T, Rogler G. Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflamm Intest Dis 2019;4:79-96. [PMID: 31559260 DOI: 10.1159/000500721] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
58 Le Barz M, Daniel N, Varin TV, Naimi S, Demers-Mathieu V, Pilon G, Audy J, Laurin É, Roy D, Urdaci MC, St-Gelais D, Fliss I, Marette A. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity. FASEB J 2019;33:4921-35. [PMID: 30596521 DOI: 10.1096/fj.201801672R] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
59 Althubiani AS, Al-ghamdi SB, Samreen, Qais FA, Khan MS, Ahmad I, Malak HA. Plant-Derived Prebiotics and Its Health Benefits. New Look to Phytomedicine. Elsevier; 2019. pp. 63-88. [DOI: 10.1016/b978-0-12-814619-4.00004-5] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Koopman JE, Hoogenkamp MA, Buijs MJ, Brandt BW, Keijser BJ, Crielaard W, Ten Cate JM, Zaura E. Changes in the oral ecosystem induced by the use of 8% arginine toothpaste. Arch Oral Biol 2017;73:79-87. [PMID: 27697693 DOI: 10.1016/j.archoralbio.2016.09.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
61 Pérez-Pérez M, Pérez-Rodríguez G, Fdez-Riverola F, Lourenço A. Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics. J Med Internet Res 2019;21:e12610. [PMID: 31411142 DOI: 10.2196/12610] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
62 Notararigo S, Varela E, Otal A, Cristobo I, Antolín M, Guarner F, Prieto A, López P. Evaluation of an O2-Substituted (1-3)-β-D-Glucan, Produced by Pediococcus parvulus 2.6, in ex vivo Models of Crohn's Disease. Front Microbiol 2021;12:621280. [PMID: 33613490 DOI: 10.3389/fmicb.2021.621280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Chen F, Yan CK. Recent progress in drug therapy of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2016; 24(12): 1840-1845 [DOI: 10.11569/wcjd.v24.i12.1840] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Argollo M, Kotze PG, Lamonaca L, Gilardi D, Furfaro F, Yamamoto T, Danese S. Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile. Curr Drug Targets 2019;20:1327-38. [PMID: 30894106 DOI: 10.2174/1389450120666190320110809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Hasannejad-Bibalan M, Mojtahedi A, Eshaghi M, Rohani M, Pourshafie MR, Talebi M. The effect of selected Lactobacillus strains on dextran sulfate sodium-induced mouse colitis model. Acta Microbiol Immunol Hung 2020;67:138-42. [PMID: 32554841 DOI: 10.1556/030.2020.00834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
66 Wu N, Mah C, Koentgen S, Zhang L, Grimm MC, El-Omar E, Hold GL. Inflammatory bowel disease and the gut microbiota. Proc Nutr Soc 2021;:1-11. [PMID: 34165053 DOI: 10.1017/S002966512100197X] [Reference Citation Analysis]
67 Xie J, Liu Y, Chen B, Zhang G, Ou S, Luo J, Peng X. Ganoderma lucidum polysaccharide improves rat DSS-induced colitis by altering cecal microbiota and gene expression of colonic epithelial cells. Food Nutr Res 2019;63. [PMID: 30814921 DOI: 10.29219/fnr.v63.1559] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
68 Brusaferro A, Cavalli E, Farinelli E, Cozzali R, Principi N, Esposito S. Gut dysbiosis and paediatric Crohn's disease. J Infect 2019;78:1-7. [PMID: 30336176 DOI: 10.1016/j.jinf.2018.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
69 Kanmani P, Kim H. Protective Effects of Lactic Acid Bacteria Against TLR4 Induced Inflammatory Response in Hepatoma HepG2 Cells Through Modulation of Toll-Like Receptor Negative Regulators of Mitogen-Activated Protein Kinase and NF-κB Signaling. Front Immunol 2018;9:1537. [PMID: 30022981 DOI: 10.3389/fimmu.2018.01537] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
70 Yue B, Yu ZL, Lv C, Geng XL, Wang ZT, Dou W. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol 2020; 26(30): 4378-4393 [PMID: 32874052 DOI: 10.3748/wjg.v26.i30.4378] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Wang W, Yang GJ, Zhang J, Chen C, Jia ZY, Li J, Xu WD. Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles. Arthritis Res Ther 2016;18:244. [PMID: 27770826 DOI: 10.1186/s13075-016-1139-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
72 Jiang C, Li G, Huang P, Liu Z, Zhao B. The Gut Microbiota and Alzheimer's Disease. J Alzheimers Dis. 2017;58:1-15. [PMID: 28372330 DOI: 10.3233/jad-161141] [Cited by in Crossref: 279] [Cited by in F6Publishing: 156] [Article Influence: 69.8] [Reference Citation Analysis]
73 Floch MH. The Role of Prebiotics and Probiotics in Gastrointestinal Disease. Gastroenterol Clin North Am 2018;47:179-91. [PMID: 29413011 DOI: 10.1016/j.gtc.2017.09.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
74 Bakir-gungor B, Hacılar H, Jabeer A, Nalbantoglu OU, Aran O, Yousef M. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods. PeerJ 2022;10:e13205. [DOI: 10.7717/peerj.13205] [Reference Citation Analysis]
75 Rafeeq M, Murad HAS, Abdallah HM, El-Halawany AM. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats. BMC Complement Med Ther 2021;21:28. [PMID: 33441125 DOI: 10.1186/s12906-021-03203-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Vecchi Brumatti L, Marcuzzi A, Tricarico PM, Zanin V, Girardelli M, Bianco AM. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules. 2014;19:21127-21153. [PMID: 25521115 DOI: 10.3390/molecules191221127] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 8.8] [Reference Citation Analysis]
77 Rufino MN, Aleixo GFP, Trombine-Batista IE, Giuffrida R, Keller R, Bremer-Neto H. Systematic review and meta-analysis of preclinical trials demonstrate robust beneficial effects of prebiotics in induced inflammatory bowel disease. J Nutr Biochem. 2018;62:1-8. [PMID: 30053633 DOI: 10.1016/j.jnutbio.2018.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
78 Pereira guedes T, Alves silva J, Neves S, Falcão D, Costa P, Lago P, Pedroto I, Salgado M. Positioning Aeromonas Infection in Inflammatory Bowel Disease: A Retrospective Analysis. GE Port J Gastroenterol. [DOI: 10.1159/000520272] [Reference Citation Analysis]
79 Amiri M, Diekmann L, von Köckritz-Blickwede M, Naim HY. The Diverse Forms of Lactose Intolerance and the Putative Linkage to Several Cancers. Nutrients 2015;7:7209-30. [PMID: 26343715 DOI: 10.3390/nu7095332] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
80 Mosca A, Leclerc M, Hugot JP. Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Front Microbiol 2016;7:455. [PMID: 27065999 DOI: 10.3389/fmicb.2016.00455] [Cited by in Crossref: 189] [Cited by in F6Publishing: 179] [Article Influence: 31.5] [Reference Citation Analysis]
81 Jasso-padilla I, Juárez-flores B, Alvarez-fuentes G, De la Cruz-martínez A, González-ramírez J, Moscosa-santillán M, González-chávez M, Oros-ovalle C, Prell F, Czermak P, Martinez-gutierrez F. Effect of prebiotics of Agave salmiana fed to healthy Wistar rats: Effect of A. salmiana prebiotics in rats. J Sci Food Agric 2017;97:556-63. [DOI: 10.1002/jsfa.7764] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
82 Tang W, Huang Y, Shi P, Wang Y, Zhang Y, Xue A, Tang Z, Hu W, Sun H, Zhang P, Zheng C, Shi J, Wang S, Qiu X, Lu X, Miao S, Meng Y. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease. JPEN J Parenter Enteral Nutr 2021;45:826-38. [PMID: 32510616 DOI: 10.1002/jpen.1938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sivananthan K, Petersen AM. Review of Saccharomyces boulardii as a treatment option in IBD. Immunopharmacology and Immunotoxicology 2018;40:465-75. [DOI: 10.1080/08923973.2018.1469143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
84 Kamalian A, Sohrabi Asl M, Dolatshahi M, Afshari K, Shamshiri S, Momeni Roudsari N, Momtaz S, Rahimi R, Abdollahi M, Abdolghaffari AH. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World J Gastroenterol 2020; 26(24): 3365-3400 [PMID: 32655263 DOI: 10.3748/wjg.v26.i24.3365] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
85 Thakur BK, Saha P, Banik G, Saha DR, Grover S, Batish VK, Das S. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. International Immunopharmacology 2016;36:39-50. [DOI: 10.1016/j.intimp.2016.03.033] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
86 Belguesmia Y, Domenger D, Caron J, Dhulster P, Ravallec R, Drider D, Cudennec B. Novel probiotic evidence of lactobacilli on immunomodulation and regulation of satiety hormones release in intestinal cells. Journal of Functional Foods 2016;24:276-86. [DOI: 10.1016/j.jff.2016.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
87 Rakoff-Nahoum S, Foster KR, Comstock LE. The evolution of cooperation within the gut microbiota. Nature 2016;533:255-9. [PMID: 27111508 DOI: 10.1038/nature17626] [Cited by in Crossref: 284] [Cited by in F6Publishing: 224] [Article Influence: 47.3] [Reference Citation Analysis]
88 Gatti S, Galeazzi T, Franceschini E, Annibali R, Albano V, Verma AK, De Angelis M, Lionetti ME, Catassi C. Effects of the Exclusive Enteral Nutrition on the Microbiota Profile of Patients with Crohn's Disease: A Systematic Review. Nutrients. 2017;9:832. [PMID: 28777338 DOI: 10.3390/nu9080832] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
89 Chan JL, Wu S, Geis AL, Chan GV, Gomes TAM, Beck SE, Wu X, Fan H, Tam AJ, Chung L, Ding H, Wang H, Pardoll DM, Housseau F, Sears CL. Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A. Mucosal Immunol 2019;12:164-77. [PMID: 30279518 DOI: 10.1038/s41385-018-0085-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
90 Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2018;233:2091-2103. [PMID: 28294322 DOI: 10.1002/jcp.25911] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 25.0] [Reference Citation Analysis]
91 Serena G, Fasano A. Use of Probiotics to Prevent Celiac Disease and IBD in Pediatrics. Adv Exp Med Biol 2019;1125:69-81. [PMID: 30565165 DOI: 10.1007/5584_2018_317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
92 Zaylaa M, Al Kassaa I, Alard J, Peucelle V, Boutillier D, Desramaut J, Dabboussi F, Pot B, Grangette C. Probiotics in IBD: Combining in vitro and in vivo models for selecting strains with both anti-inflammatory potential as well as a capacity to restore the gut epithelial barrier. Journal of Functional Foods 2018;47:304-15. [DOI: 10.1016/j.jff.2018.05.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
93 Kanmani P, Ansari A, Villena J, Kim H. Immunobiotics Beneficially Modulate TLR4 Signaling Triggered by Lipopolysaccharide and Reduce Hepatic Steatosis In Vitro. J Immunol Res 2019;2019:3876896. [PMID: 31001563 DOI: 10.1155/2019/3876896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Serban DE. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Nutr Clin Pract 2015;30:760-79. [DOI: 10.1177/0884533615606898] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
95 Jergens AE, Parvinroo S, Kopper J, Wannemuehler MJ. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:669913. [PMID: 34513862 DOI: 10.3389/fmed.2021.669913] [Reference Citation Analysis]
96 Sun Y, Wang F, Liu Y, Liu S, An Y, Xue H, Wang J, Xia F, Chen X, Cao Y. Microbiome-metabolome responses of Fuzhuan brick tea crude polysaccharides with immune-protective benefit in cyclophosphamide-induced immunosuppressive mice. Food Research International 2022;157:111370. [DOI: 10.1016/j.foodres.2022.111370] [Reference Citation Analysis]